| Year |
Citation |
Score |
| 1988 |
Silagi S, Dutkowski R, Schaefer A. Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma. International Journal of Cancer. 41: 315-22. PMID 3123404 DOI: 10.1002/Ijc.2910410225 |
0.402 |
|
| 1988 |
Silagi S, Dutkowski R, Schaefer A. In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma. Anticancer Research. 8: 1265-9. PMID 2905882 |
0.365 |
|
| 1986 |
Pinter A, Chen TE, Lowy A, Cortez NG, Silagi S. Ecotropic murine leukemia virus-induced fusion of murine cells. Journal of Virology. 57: 1048-54. PMID 3005611 |
0.415 |
|
| 1986 |
Pinter A, Chen TE, Lowy A, Cortez NG, Silagi S. Ecotropic murine leukemia virus-induced fusion of murine cells. Journal of Virology. 57: 1048-1054. DOI: 10.1128/jvi.57.3.1048-1054.1986 |
0.323 |
|
| 1984 |
Graf LH, Kaplan P, Silagi S. Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somatic Cell and Molecular Genetics. 10: 139-51. PMID 6324393 DOI: 10.1007/Bf01534903 |
0.308 |
|
| 1982 |
Silagi S, Calvelli TA. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice. Cancer Research. 42: 2562-6. PMID 7083149 |
0.444 |
|
| 1982 |
Calvelli TA, Freedman VH, Silverstein SC, Silagi S. Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: Their role in direct rejection of the melanoma and prevention of tumorigenesis in Winn assays Journal of Experimental Medicine. 156: 1723-1738. PMID 6983560 DOI: 10.1084/Jem.156.6.1723 |
0.436 |
|
| 1981 |
Weintraub SB, Calvelli TA, Silagi S. Immunization of syngeneic mice against malignant melanoma with subcellular membrane fractions of a bromodeoxyuridine-grown variant Cancer Immunology, Immunotherapy. 12: 63-70. DOI: 10.1007/Bf00200314 |
0.491 |
|
| 1980 |
Freedman VH, Calvelli TA, Silagi S, Silverstein SC. Macrophages elicited with heat-killed bacillus Calmette-Guerin protect C57BL/6J mice against a syngeneic melanoma Journal of Experimental Medicine. 152: 657-673. PMID 6997425 DOI: 10.1084/Jem.152.3.657 |
0.364 |
|
| 1979 |
Levy JA, Rutledge F, Dimpfl J, Silagi S. Recovery of three distinct biologically active type C viruses from cloned C57Bl/6 melanoma cells. The Journal of General Virology. 43: 283-8. PMID 225423 DOI: 10.1099/0022-1317-43-2-283 |
0.302 |
|
| 1978 |
Newcomb EW, Silverstein SC, Silagi S. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response. Journal of Cellular Physiology. 95: 169-77. PMID 306389 DOI: 10.1002/Jcp.1040950206 |
0.48 |
|
| 1978 |
Kyner D, Christman J, Acs G, Silagi S, Newcomb EW, Silverstein SC. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells. Journal of Cellular Physiology. 95: 159-67. PMID 206566 DOI: 10.1002/Jcp.1040950205 |
0.592 |
|
| 1977 |
Zeitz L, Silagi S. Radiosensitivity of melanoma cells in culture: implications for radiotherapy of malignant melanoma British Journal of Radiology. 50: 604-606. PMID 890242 |
0.359 |
|
| 1977 |
Silagi S, Balint RF, Gauri KK. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine. Cancer Research. 37: 3367-73. PMID 884681 |
0.46 |
|
| 1977 |
Silagi S. Reversible suppression of malignancy and differentiation of melanoma cells. The American Journal of Pathology. 89: 671-84. PMID 596422 |
0.438 |
|
| 1976 |
Silagi S. Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells. International Review of Cytology. 45: 65-111. PMID 821894 DOI: 10.1016/S0074-7696(08)60078-9 |
0.544 |
|
| 1975 |
Wrathall JR, Newcomb EW, Balint R, Zeitz L, Silagi S. Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions. Journal of Cellular Physiology. 86: 581-92. PMID 811676 DOI: 10.1002/Jcp.1040860503 |
0.677 |
|
| 1975 |
Christman JK, Silagi S, Newcomb EW, Silverstein SC, Acs G. Correlated suppression by 5 bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells Proceedings of the National Academy of Sciences of the United States of America. 72: 47-50. PMID 123336 DOI: 10.1073/Pnas.72.1.47 |
0.551 |
|
| 1974 |
Schulman JD, Wrathall JR, Silagi S, Doores L. Altered amino acid concentrations accompanying suppression of malignancy of mouse melanoma cells by 5 bromodeoxyuridine Journal of the National Cancer Institute. 52: 275-277. PMID 4855760 DOI: 10.1093/Jnci/52.1.275 |
0.639 |
|
| 1974 |
Silagi S, Newcomb EW, Weksler ME. Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity. Cancer Research. 34: 100-4. PMID 4358536 |
0.377 |
|
| 1973 |
Wrathall JR, Oliver C, Silagi S, Essner E. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation Journal of Cell Biology. 57: 406-423. PMID 4633171 DOI: 10.1083/Jcb.57.2.406 |
0.632 |
|
| 1972 |
Silagi S, Beju D, Wrathall J, Deharven E. Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine. Proceedings of the National Academy of Sciences of the United States of America. 69: 3443-7. PMID 4343973 DOI: 10.1073/Pnas.69.11.3443 |
0.657 |
|
| 1971 |
Bart RS, Kopf AW, Silagi S. Inhibition of the growth of murine malignant melanoma by polyinosinic-polycytidylic acid Journal of Investigative Dermatology. 56: 33-38. PMID 5556497 DOI: 10.1111/1523-1747.Ep12291892 |
0.378 |
|
| 1971 |
Silagi S. Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects. In Vitro. 7: 105-14. PMID 5170776 DOI: 10.1007/Bf02628269 |
0.466 |
|
| 1970 |
Ruddle FH, Chen T, Shows TB, Silagi S. Interstrain somatic cell hybrids in the mouse. Chromosome and enzyme analyses. Experimental Cell Research. 60: 139-47. PMID 5424308 DOI: 10.1016/0014-4827(70)90499-4 |
0.344 |
|
| 1970 |
Silagi S, Bruce SA. Suppression of malignancy and differentiation in melanotic melanoma cells Proceedings of the National Academy of Sciences of the United States of America. 66: 72-78. PMID 4921328 DOI: 10.1073/Pnas.66.1.72 |
0.681 |
|
| 1969 |
Silagi S, Darlington G, Bruce SA. Hybridization of two biochemically marked human cell lines Proceedings of the National Academy of Sciences of the United States of America. 62: 1085-1092. PMID 5256409 |
0.605 |
|
| 1969 |
Silagi S. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance. The Journal of Cell Biology. 43: 263-74. PMID 4981070 DOI: 10.1083/Jcb.43.2.263 |
0.504 |
|
| 1967 |
Silagi S. Hybridization of a malignant melanoma cell line with L cells in vitro. Cancer Research. 27: 1953-60. PMID 6073493 |
0.437 |
|
| Show low-probability matches. |